Digital health technologies and artificial intelligence in cardiovascular clinical trials: A landscape of the European space.

ABSTRACT: The recent pandemic ushered in a marked surge in the adoption of digital health technologies (DHTs), necessitating remote approaches aiming to safeguard both patient and healthcare provider well-being. These technologies encompass an array of terms, including e-health, m-health, telemedicine, wearables, sensors, smartphone apps, digital therapeutics, virtual and augmented reality, and artificial intelligence (AI). Notably, some DHTs employed in critical healthcare decisions may transition into the realm of medical devices, subjecting them to more stringent regulatory scrutiny. Consequently, it is imperative to understand the validation processes of these technologies within clinical studies. Our study summarizes an extensive examination of clinical trials focusing on cardiovascular (CV) di

SUBMITTER: Lampreia F 

PROVIDER: S-EPMC11406593 | biostudies-literature | 2024 Jan-Dec

REPOSITORIES: biostudies-literature